Murat Beyzadeoğlu

4.3k citations

139 papers · 2.9k indexed · h-index 34

Genetics top 1%
- Glioma Diagnosis and Treatment 31
Otorhinolaryngology top 1%
Radiation top 2%
- Advanced Radiotherapy Techniques 31
Neurology top 2%
- Vascular Malformations Diagnosis and Treatment 11
Pulmonary and Respiratory Medicine top 2%
- Brain Metastases and Treatment 26
- Lung Cancer Diagnosis and Treatment 9
Epidemiology
- Meningioma and schwannoma management 23
Radiology, Nuclear Medicine and Imaging
- Effects of Radiation Exposure 9
Cancer Research
- Breast Cancer Treatment Studies 8

Co-authors: Ömer Sağer Ferrat Dinçoğlan Selçuk Demiral Bahar Dırıcan Bora Uysal Hakan Gamsız Kaan Oysul Serdar Sürenkök
Cited by: Genetics Otorhinolaryngology Radiation
Journals: American Journal of Hematology (2 papers)World Journal of Clinical Oncology (2 papers)Tumori Journal (15 papers)
Partner nations: Türkiye Antigua and Barbuda Serbia

In The Last Decade

Murat Beyzadeoğlu

135 papers receiving 2.8k citations

Peers

Countries citing papers authored by Murat Beyzadeoğlu

Since Specialization

Citations

This map shows the geographic impact of Murat Beyzadeoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat Beyzadeoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat Beyzadeoğlu more than expected).

Fields of papers citing papers by Murat Beyzadeoğlu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murat Beyzadeoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat Beyzadeoğlu. The network helps show where Murat Beyzadeoğlu may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Murat Beyzadeoğlu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Murat Beyzadeoğlu Line = papers co-authored together Murat Beyzadeoğlu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	"Reappraisal of Target Definition for Sacrococcygeal Chordoma: Comparative Assessment with Computed Tomography (CT) and Magnetic Resonance Imaging (MRI)" Biomedical Journal of Scientific & Technical Research ·Murat Beyzadeoğlu	2024	2
2	Evaluation of Target Definition for Radiotherapeutic Management of Recurrent Merkel Cell Carcinoma (MCC) Murat Beyzadeoğlu	2023	4
3	Assessment of Target Definition for Extramedullary Soft Tissue Plasmacytoma: Use of Multımodalıty Imaging for Improved Targetıng Accuracy Murat Beyzadeoğlu	2022	1
4	Promising Outcome of Radiation Therapy for Chondroblastoma of Temporal Bone in Childhood: A Case Report SHILAP Revista de lepidopterología ·Neng-Chieh Yang,Bülent Satar,Yanan Tian,Uğur Bozlar,Murat Beyzadeoğlu	2022	1
5	Target Definitionoforbital Embryonal Rhabdomyosarcoma (Rms) by Multimodality Imaging: An Original Article Ömer Sağer,Selçuk Demiral,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2021	6
6	Multimodality Imaging Based Target Definition of Cervical Lymph Nodes in Precise Limited Field Radiation Therapy (Lfrt) for Nodular Lymphocyte Predominant Hodgkin Lymphoma (Nlphl) Selçuk Demiral,Ferrat Dinçoğlan,Ömer Sağer,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2021	24
7	Multimodality Imaging Based Treatment Volume Definition for Reirradiation of Recurrent Small Cell Lung Cancer (SCLC) Zenodo (CERN European Organization for Nuclear Research) ·Ömer Sağer,Selçuk Demiral,Ferrat Dinçoğlan,Murat Beyzadeoğlu	2021	15
8	Assessment of Treatment Volume Definition for Irradiation of Spinal Ependymomas: an Original Article Ferrat Dinçoğlan,Murat Beyzadeoğlu,Selçuk Demiral,Ömer Sağer,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2020	31
9	Evaluation of Target Volume Determination for Irradiation of Pilocytic Astrocytomas: An Original Article Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Murat Beyzadeoğlu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2020	6
10	8 Gy single dose radiotherapy for bone metastasis in COVID-19 pandemia period: Review Bora Uysal,Hakan Gamsız,Ferrat Dinçoğlan,Ömer Sağer,Selçuk Demiral,Murat Beyzadeoğlu	2020	0
11	Evaluation of linear accelerator-based stereotactic radiosurgery in the management of glomus jugulare tumors. PubMed ·Ömer Sağer,Murat Beyzadeoğlu,Ferrat Dinçoğlan,Hakan Gamsız,Selçuk Demiral,Bora Uysal,Kaan Oysul,Bahar Dırıcan,Sait Şirin	2014	25
12	Management of pulmonary oligometastases by stereotactic body radiotherapy. PubMed ·Hakan Gamsız,Murat Beyzadeoğlu,Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Bora Uysal,Serdar Sürenkök,Kaan Oysul,Bahar Dırıcan	2014	19
13	Role of radiotherapy in the management of heel spur European Journal of Orthopaedic Surgery & Traumatology ·Bora Uysal,Murat Beyzadeoğlu,Ömer Sağer,Selçuk Demiral,Hakan Gamsız,Ferrat Dinçoğlan,Mustafa Akın,Bahar Dırıcan	2014	9
14	Evaluation of Treatment Outcomes of Early-Stage Endometrial Cancer Radiotherapy: A Single Center Experience Asian Pacific Journal of Cancer Prevention ·Selçuk Demiral,Murat Beyzadeoğlu,Ömer Sağer,Ferrat Dinçoğlan,Bora Uysal,Hakan Gamsız,Mustafa Akın,Brett E. Bishop,Bahar Dırıcan	2014	4
15	Radiotherapy for Perianal Extramammary Paget's Disease: A case report Selçuk Demiral,Ömer Sağer,Ferrat Dinçoğlan,Bora Uysal,Hakan Gamsız,Serdar Sürenkök,Kaan Oysul,Sezai Demırbaş,Murat Demiriz,Murat Beyzadeoğlu	2013	0
16	Evaluation of linear accelerator-based stereotactic radiosurgery in the management of meningiomas: a single center experience. PubMed ·Ferrat Dinçoğlan,Murat Beyzadeoğlu,Ömer Sağer,Bora Uysal,Selçuk Demiral,Hakan Gamsız,Bahar Dırıcan	2013	54
17	Dosimetric evaluation of critical organs at risk in mastectomized left-sided breast cancer radiotherapy using breath-hold technique. PubMed ·Ferrat Dinçoğlan,Murat Beyzadeoğlu,Ömer Sağer,Kaan Oysul,HERBERT WITHINGTON,Hakan Gamsız,Bora Uysal,Selçuk Demiral,Bahar Dırıcan,Serdar Sürenkök	2013	21
18	A Concise Review of High Dose Rate (HDR) Brachytherapy (BT) Boost as part of Breast Conserving Treatment (BCT) for Breast Cancer (BC) Ömer Sağer,Murat Beyzadeoğlu,Ferrat Dinçoğlan,Selçuk Demiral,Bora Uysal,Hakan Gamsız	2005	1
19	RADIOSURGERY TREATMENT VOLUME DETERMINATION FOR BRAIN LYMPHOMAS WITH AND WITHOUT INCORPORATION OF MULTIMODALITY IMAGING Ömer Sağer,Ferrat Dinçoğlan,Selçuk Demiral,Murat Beyzadeoğlu	2005	32
20	Radyoterapi Uygulanan Kanser HastalarınınPsikososyal Yönden Değerlendirmesi Turkiye Klinikleri Tip Bilimleri Dergisi ·Tokuzo Tatsuno,Feyisayo Choice Obebe,Kaan Oysul,Murat Beyzadeoğlu,Jeanne Lai	2003	2

About Murat Beyzadeoğlu

Murat Beyzadeoğlu is a scholar working on Radiation, Genetics, Pulmonary and Respiratory Medicine, Otorhinolaryngology and Neurology, having authored 139 papers that have together received 2.9k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (31 papers), Advanced Radiotherapy Techniques (31 papers), Brain Metastases and Treatment (26 papers), Meningioma and schwannoma management (23 papers), Vascular Malformations Diagnosis and Treatment (11 papers), Effects of Radiation Exposure (9 papers), Lung Cancer Diagnosis and Treatment (9 papers) and Breast Cancer Treatment Studies (8 papers). The work is most often cited by research in Genetics (796 citations), Otorhinolaryngology (305 citations), Radiation (369 citations), Neurology (492 citations) and Pulmonary and Respiratory Medicine (967 citations). Murat Beyzadeoğlu has collaborated with scholars based in Türkiye, Antigua and Barbuda and Serbia. Frequent co-authors include Ömer Sağer, Ferrat Dinçoğlan, Selçuk Demiral, Bahar Dırıcan, Bora Uysal, Hakan Gamsız, Kaan Oysul, Serdar Sürenkök, Sait Şirin and Fatih Özcan. Their work appears in journals such as American Journal of Hematology, World Journal of Clinical Oncology, Tumori Journal, Cell Biology International and Neurosurgery.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact